Cargando…

An update on T2-toxins: metabolism, immunotoxicity mechanism and human assessment exposure of intestinal microbiota

Mycotoxins are naturally produced secondary metabolites or low molecular organic compounds produced by fungus with high diversification, which cause mycotoxicosis (food contamination) in humans and animals. T-2 toxin is simply one of the metabolites belonging to fungi trichothecene mycotoxin. Specif...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jie, Liu, Xuerun, Su, Ying, Li, Tushuai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344027/
https://www.ncbi.nlm.nih.gov/pubmed/35928103
http://dx.doi.org/10.1016/j.heliyon.2022.e10012
_version_ 1784761124014522368
author Zhang, Jie
Liu, Xuerun
Su, Ying
Li, Tushuai
author_facet Zhang, Jie
Liu, Xuerun
Su, Ying
Li, Tushuai
author_sort Zhang, Jie
collection PubMed
description Mycotoxins are naturally produced secondary metabolites or low molecular organic compounds produced by fungus with high diversification, which cause mycotoxicosis (food contamination) in humans and animals. T-2 toxin is simply one of the metabolites belonging to fungi trichothecene mycotoxin. Specifically, Trichothecenes-2 (T-2) mycotoxin of genus fusarium is considered one of the most hotspot agricultural commodities and carcinogenic compounds worldwide. There are well-known examples of salmonellosis in mice and pigs, necrotic enteritis in chickens, catfish enteric septicemia and colibacillosis in pigs as T-2 toxic agent. On the other hand, it has shown a significant reduction in the Salmonella population's aptitude in the pig intestinal tract. Although the impact of the excess Fusarium contaminants on humans in creating infectious illness is less well-known, some toxins are harmful; for example, salmonellosis and colibacillosis have been frequently observed in humans. More than 20 different metabolites are synthesized and excreted after ingestion, but the T-2 toxin is one of the most protuberant metabolites. Less absorption of mycotoxins in intestinal tract results in biotransformation of toxic metabolites into less toxic variants. In addition to these, effects of microbiota on harmful mycotoxins are not limited to intestinal tract, it may harm the other human vital organs. However, detoxification of microbiota is considered as an alternative way to decontaminate the feed for both animals and humans. These transformations of toxic metabolites depend upon the formation of metabolites. This study is complete in all perspectives regarding interactions between microbiota and mycotoxins, their mechanism and practical applications based on experimental studies.
format Online
Article
Text
id pubmed-9344027
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-93440272022-08-03 An update on T2-toxins: metabolism, immunotoxicity mechanism and human assessment exposure of intestinal microbiota Zhang, Jie Liu, Xuerun Su, Ying Li, Tushuai Heliyon Review Article Mycotoxins are naturally produced secondary metabolites or low molecular organic compounds produced by fungus with high diversification, which cause mycotoxicosis (food contamination) in humans and animals. T-2 toxin is simply one of the metabolites belonging to fungi trichothecene mycotoxin. Specifically, Trichothecenes-2 (T-2) mycotoxin of genus fusarium is considered one of the most hotspot agricultural commodities and carcinogenic compounds worldwide. There are well-known examples of salmonellosis in mice and pigs, necrotic enteritis in chickens, catfish enteric septicemia and colibacillosis in pigs as T-2 toxic agent. On the other hand, it has shown a significant reduction in the Salmonella population's aptitude in the pig intestinal tract. Although the impact of the excess Fusarium contaminants on humans in creating infectious illness is less well-known, some toxins are harmful; for example, salmonellosis and colibacillosis have been frequently observed in humans. More than 20 different metabolites are synthesized and excreted after ingestion, but the T-2 toxin is one of the most protuberant metabolites. Less absorption of mycotoxins in intestinal tract results in biotransformation of toxic metabolites into less toxic variants. In addition to these, effects of microbiota on harmful mycotoxins are not limited to intestinal tract, it may harm the other human vital organs. However, detoxification of microbiota is considered as an alternative way to decontaminate the feed for both animals and humans. These transformations of toxic metabolites depend upon the formation of metabolites. This study is complete in all perspectives regarding interactions between microbiota and mycotoxins, their mechanism and practical applications based on experimental studies. Elsevier 2022-07-20 /pmc/articles/PMC9344027/ /pubmed/35928103 http://dx.doi.org/10.1016/j.heliyon.2022.e10012 Text en © 2022 Published by Elsevier Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Review Article
Zhang, Jie
Liu, Xuerun
Su, Ying
Li, Tushuai
An update on T2-toxins: metabolism, immunotoxicity mechanism and human assessment exposure of intestinal microbiota
title An update on T2-toxins: metabolism, immunotoxicity mechanism and human assessment exposure of intestinal microbiota
title_full An update on T2-toxins: metabolism, immunotoxicity mechanism and human assessment exposure of intestinal microbiota
title_fullStr An update on T2-toxins: metabolism, immunotoxicity mechanism and human assessment exposure of intestinal microbiota
title_full_unstemmed An update on T2-toxins: metabolism, immunotoxicity mechanism and human assessment exposure of intestinal microbiota
title_short An update on T2-toxins: metabolism, immunotoxicity mechanism and human assessment exposure of intestinal microbiota
title_sort update on t2-toxins: metabolism, immunotoxicity mechanism and human assessment exposure of intestinal microbiota
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344027/
https://www.ncbi.nlm.nih.gov/pubmed/35928103
http://dx.doi.org/10.1016/j.heliyon.2022.e10012
work_keys_str_mv AT zhangjie anupdateont2toxinsmetabolismimmunotoxicitymechanismandhumanassessmentexposureofintestinalmicrobiota
AT liuxuerun anupdateont2toxinsmetabolismimmunotoxicitymechanismandhumanassessmentexposureofintestinalmicrobiota
AT suying anupdateont2toxinsmetabolismimmunotoxicitymechanismandhumanassessmentexposureofintestinalmicrobiota
AT litushuai anupdateont2toxinsmetabolismimmunotoxicitymechanismandhumanassessmentexposureofintestinalmicrobiota
AT zhangjie updateont2toxinsmetabolismimmunotoxicitymechanismandhumanassessmentexposureofintestinalmicrobiota
AT liuxuerun updateont2toxinsmetabolismimmunotoxicitymechanismandhumanassessmentexposureofintestinalmicrobiota
AT suying updateont2toxinsmetabolismimmunotoxicitymechanismandhumanassessmentexposureofintestinalmicrobiota
AT litushuai updateont2toxinsmetabolismimmunotoxicitymechanismandhumanassessmentexposureofintestinalmicrobiota